| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.39B | 90.51B | 84.01B | 82.91B | 74.87B | 64.86B |
| Gross Profit | 28.81B | 28.09B | 25.55B | 26.57B | 23.43B | 18.99B |
| EBITDA | 13.83B | 17.48B | 14.61B | 13.13B | 12.65B | 9.89B |
| Net Income | 6.69B | 9.06B | 7.10B | 7.07B | 6.38B | 4.07B |
Balance Sheet | ||||||
| Total Assets | 125.76B | 128.16B | 135.63B | 121.68B | 118.96B | 108.06B |
| Cash, Cash Equivalents and Short-Term Investments | 29.02B | 31.58B | 35.85B | 35.31B | 34.71B | 33.77B |
| Total Debt | 5.05B | 5.67B | 6.42B | 8.94B | 4.74B | 5.58B |
| Total Liabilities | 31.72B | 32.37B | 37.38B | 34.08B | 32.08B | 29.80B |
| Stockholders Equity | 94.04B | 95.79B | 98.25B | 87.60B | 86.88B | 78.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 758.00M | 6.88B | 3.74B | 2.99B | 4.89B |
| Operating Cash Flow | 0.00 | 7.75B | 11.93B | 9.34B | 9.04B | 8.61B |
| Investing Cash Flow | 0.00 | -3.62B | -2.67B | -7.00B | -7.38B | -3.07B |
| Financing Cash Flow | 0.00 | -8.24B | -9.47B | -3.74B | -3.25B | -4.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥256.39B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥112.14B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
77 Outperform | ¥90.37B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥116.37B | 0.96 | ― | 1.43% | -1.38% | 327.52% | |
75 Outperform | ¥145.44B | 12.83 | ― | 3.47% | 3.93% | 68.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥31.44B | 4.17 | ― | 2.13% | 1.13% | -66.14% |